Form 4 for CDNA CareDx, Inc.
Accepted 2023-07-13 00:00:00 ET · period of report 2023-07-13 · accession 0001217234-23-000160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-13 | 2023-07-13 | CDNA | Seeto Reginald | See Remarks, Dir | S - Sale | $10.33 | -5,260 | 488.9K | -1% | -$54.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-13 | S | D | 5,260 | $10.33 | 488,870 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. (F3) Includes 815 shares acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan. |